Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2017 Mar;105(3):265-271.
doi: 10.1007/s12185-016-2140-x. Epub 2016 Nov 15.

Characterization of circulating CD4+ CD8+ double positive and CD4- CD8- double negative T-lymphocyte in children with β-thalassemia major

Affiliations
Clinical Trial

Characterization of circulating CD4+ CD8+ double positive and CD4- CD8- double negative T-lymphocyte in children with β-thalassemia major

Asmaa M Zahran et al. Int J Hematol. 2017 Mar.

Abstract

Infectious complications represent the second most common cause of mortality and a major cause of morbidity in β-thalassemia major (BTM), with a prevalence of 12-13%. The data on unconventional T-lymphocyte subsets in BTM children are limited. The aim of the present study was to investigate and evaluate phenotypic alterations in CD4+CD8+ double positive (DP), CD4- CD8- double negative (DN), and natural killer T-lymphocytes (NKT) in BTM children in comparison to healthy controls. Our case control study included 80 children with BTM and 40 healthy children as controls. Assessment of unconventional T-lymphocyte populations was done using sensitive four-color flow cytometry (FACSCalibur). Our analysis of the data showed a significantly higher frequency CD4+ CD8+ (double-positive) T cells, CD4- CD8- (double negative) T cells, and natural killer T cells in the peripheral blood of both BTM groups (splenectomized and non-splenectomized) as compared to healthy controls, suggesting that these cells may play a role in the clinical course of BTM. The relationship of the unconventional T-lymphocytes to immune disorders in BTM children remains to be determined. Further longitudinal study with a larger sample size is warranted to elucidate the role these cells in BTM.

Umin-ctr study design: TRIAL NUMBER: UMIN000018950.

Keywords: CD4+ CD8+; CD4− CD8−; NKT; T-lymphocytes; Β-thalassemia major.

PubMed Disclaimer

References

    1. J Immunol. 2008 Jul 1;181(1):440-8 - PubMed
    1. Nat Rev Immunol. 2004 Mar;4(3):231-7 - PubMed
    1. PLoS One. 2014 Mar 25;9(3):e93293 - PubMed
    1. Clin Exp Med. 2016 Aug;16(3):345-50 - PubMed
    1. Blood. 2009 Jul 16;114(3):667-76 - PubMed

Publication types

LinkOut - more resources